Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis. - Taylor, P; Steuer, A; Gruber, J; McClinton, C; Cosgrove, D; Blomley, M; Wagner, C; Marsters, P; Maini, R (2002)